Is Acasti Pharma (ACST) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
Acasti Pharma, Inc. - Class A (ACST)
Last acasti pharma, inc. - class a earnings: 2/14 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
acastipharma.com/investors
Company Research
Source: Yahoo! Finance
Let's take a closer look at the stock's year-to-date performance to find out. Acasti Pharma is a member of our Medical group, which includes 1026 different companies and currently sits at #6 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Acasti Pharma is currently sporting a Zacks Rank of #2 (Buy). Within the past quarter, the Zacks Consensus Estimate for ACST's full-year earnings has moved 11.6% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving. Based on the most recent data, ACST has returned 5.9% so far this year. In
Show less
Read more
Impact Snapshot
Event Time:
ACST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACST alerts
High impacting Acasti Pharma, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
ACST
News
- Acasti to Present at the Life Sciences Investor ForumGlobeNewswire
- Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewswire
- Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business UpdateGlobeNewswire
- Is Acasti Pharma (NASDAQ:ACST) In A Good Position To Invest In Growth? [Yahoo! Finance]Yahoo! Finance
- Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial [Yahoo! Finance]Yahoo! Finance
ACST
Earnings
- 8/9/24 - Beat
ACST
Sec Filings
- 9/6/24 - Form DEFA14A
- 8/16/24 - Form 8-K
- 8/9/24 - Form 8-K
- ACST's page on the SEC website